CDC updates pain care guidelines for clinicians

Pain affects the lives of millions of Americans every day and improving pain care and the lives of patients with pain is a public health imperative. The Centers for Disease Control and Prevention (CDC) is releasing updated and expanded recommendations for clinicians providing pain care for adult outpatients with short- and long-term pain. These clinical recommendations, published in the CDC Clinical Practice Guideline for Prescribing Opioids for Pain, will help clinicians work with their patients to ensure the safest and most effective pain care is provided. The publication updates and replaces the CDC Guideline for Prescribing Opioids for Chronic Pain released in 2016.

Patients with pain should receive compassionate, safe, and effective pain care. We want clinicians and patients to have the information they need to weigh the benefits of different approaches to pain care, with the goal of helping people reduce their pain and improve their quality of life."

Christopher M. Jones, PharmD, DrPH, MPH, Acting Director of CDC's National Center for Injury Prevention and Control

The 2022 Clinical Practice Guideline addresses the following areas: 1) determining whether to initiate opioids for pain, 2) selecting opioids and determining opioid dosages, 3) deciding duration of initial opioid prescription and conducting follow-up, and 4) assessing risk and addressing potential harms of opioid use. The Clinical Practice Guideline supports the primary prevention pillar of the HHS Overdose Prevention Strategy – supporting the development and promotion of evidence-based treatments to effectively manage pain.

The guideline is a clinical tool to improve communication between clinicians and patients and empower them to make informed decisions about safe and effective pain care. The recommendations are voluntary and provide flexibility to clinicians and patients to support individualized, patient-centered care. They should not be used as an inflexible, one-size-fits-all policy or law or applied as a rigid standard of care or to replace clinical judgement about personalized treatment.

CDC followed a rigorous scientific process using the best available evidence and expert consultation to develop the 2022 Clinical Practice Guideline. An independent federal advisory committee, four peer reviewers, and members of the public reviewed the draft updated guideline, and CDC revised it in response to this feedback to foster a collaborative and transparent process. CDC also engaged with patients with pain, caregivers, and clinicians to gain insights and gather feedback from people directly impacted by the guideline. The expanded guideline aims to ensure equitable access to effective, informed, individualized, and safe pain care.

"The science on pain care has advanced over the past six years," said Debbie Dowell, MD, MPH, chief clinical research officer for CDC's Division of Overdose Prevention. "During this time, CDC has also learned more from people living with pain, their caregivers, and their clinicians. We've been able to improve and expand our recommendations by incorporating new data with a better understanding of people's lived experiences and the challenges they face when managing pain and pain care."

CDC will continue to work to improve patient safety and outcomes by equipping health care professionals and patients with data, tools, and guidance they need to make informed treatment decisions. The 2022 Clinical Practice Guideline supports patients and clinicians working together to make informed, individualized decisions about safe and effective pain care.

Additional materials associated with the guideline are available for patients and clinicians.

Comments

  1. AngelsFire A AngelsFire A United States says:

    Maybe stop having the DEA arrest doctors for prescribing pain meds.

  2. Mike Hogan Sr Mike Hogan Sr United States says:

    Hello whomever I'm a chronic pain patient suffering from spinal stenosis along with 4 bulging discs in lower back ,not once have I seen mentioned using medical cannibis in place of opioids the stereo type needs to stop because cannibis works for chronic pain without worrying about addiction or overdose the medical world's view needs to change on using cannibis for medical use it has so many avenues for use not just chronic pain I pray the day comes that the Fda and medical field realizes what a benefit it would be to many people.

  3. Judith Di Fonzo Judith Di Fonzo United States says:

    I am diagnosed with lumbar fractures, herniated & bulging discs, scoliosis & painful Ehlers Danlos hypermobility plus destroyed  ACLs & MCLs. I can't take NSAIDS & I have hypertension. The orthopedist gave me an NSAID prescription saying I could get addicted to stronger relief medication. I am in my late 70's & my life has been reduced no life due  to the inability to move without pain or even have painless sleep. I am so upset over this indifferent, uncaring doctor! There is no excuse for such illegitimate practice of medicine.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Telehealth mindfulness interventions significantly improve chronic pain outcomes for veterans